FdaApplication
ANDA 208043
Identifiers
- fda_app_no: ANDA208043
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS LABS FL INC |
| application_type | ANDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE | NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE | 8MG/90MG | TABLET, EXTENDED RELEASE;ORAL |
1 product